Andrea M. Lerner, MD, MS; Gregory K. Folkers, MS, MPH; Anthony S. Fauci, MD
free access
has active quiz
has multimedia
has audio
JAMA. 2020;324(19):1935-1936. doi:10.1001/jama.2020.21946
In this Viewpoint, Anthony Fauci and colleagues at NIAID emphasize the continued importance of low-tech public health practices, such as wearing masks, limiting large gatherings, hand washing, and physical distancing, to help control the COVID-19 pandemic even after safe and effective vaccines become available until distribution and uptake of vaccines confer herd immunity on a population level.
-
Conversations with Dr Bauchner:
Coronavirus Update With Rochelle Walensky, MD, MPH
-
Conversations with Dr Bauchner:
Coronavirus Update With Anthony Fauci - October 28, 2020
-
Conversations with Dr Bauchner:
Coronavirus Vaccine Update With Anthony Fauci
-
Conversations with Dr Bauchner:
Coronavirus Update With Anthony Fauci – February 3, 2021
Grace M. Lee, MD, MPH; José R. Romero, MD; Beth P. Bell, MD, MPH
free access
has active quiz
has audio
JAMA. 2020;324(19):1937-1938. doi:10.1001/jama.2020.19692
This Viewpoint reviews systems in place to monitor postlicensure vaccine safety, and recommends harmonizing end points and protocols across vaccine trials and surveillance systems to enable timely identification and reliable evaluation of potential adverse events.
-
Audio Clinical Review:
COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions
Manish M. Patel, MD; Michael L. Jackson, PhD; Jill Ferdinands, PhD
free access
has active quiz
JAMA. 2020;324(19):1939-1940. doi:10.1001/jama.2020.19328
This Viewpoint explains the “test-negative” modified case-control design commonly used for evaluating vaccine effectiveness, describes why it may be lead to biased estimates of COVID-19 vaccine effectiveness in patients with severe illness more likely to test negative, and proposes potential approaches to correcting the bias, including incorporation of clinical assessment of cases.
Eli Y. Adashi, MD, MS; I. Glenn Cohen, JD
has audio
JAMA. 2020;324(19):1941-1942. doi:10.1001/jama.2020.19059
This Viewpoint summarizes the report of the International Commission on the Clinical Use of Human Germline Genome Editing sponsored by the US National Academy of Medicine and the UK Royal Society, enumerating technical, regulatory, and ethical standards that need to be met before HHGE can be used on human embryos.
-
Conversations with Dr Bauchner:
Heritable Human Genome Editing (HHGE)—The International Commission Report